bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026
Go back to bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026| (NASDAQ: BIAF) | Delayed: 3.57 -0.09 (2.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.66 | 52 Week High | $ | |||
| Open | $3.68 | 52 Week Low | $ | |||
| Day High | $3.69 | P/E | N/A | |||
| Day Low | $3.54 | EPS | $ | |||
| Volume | 61,866 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.32 | 52 Week High | $ | |||
| Open | $0.32 | 52 Week Low | $ | |||
| Day High | $0.32 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $ | |||
| Volume | 1,362,235 | |||||



